Restasis Buyers Win Cert. Battle In Allergan Monopoly Case
Health care plans, welfare funds and other buyers of Allergan's extremely successful dry eye treatment Restasis have won class certification in the sweeping litigation accusing the drugmaker of illegally keeping generic...To view the full article, register now.
Already a subscriber? Click here to view full article